Elsevier, Embase

Elsevier introduces Embase AI to transform how users discover, analyze and draw critical insights from biomedical research

07.08.2025 - 18:05:13 | prnewswire.co.uk

Elsevier Limited England United States of America United Kingdom

Embase AI transforms access to biomedical research by introducing natural language search and summarization of millions of biomedical literature records, clinical trials and conference proceedingsKey benefits include easy access for all users regardless of their technical background, finding insights faster, and increasing confidence in decision-makingEmbase AI has been built in partnership with the research community to help users more easily discover, analyze and synthesize research using trusted data powered by responsible AIand Privacy Principles to ensure the highest standards of data privacy and security. Embase AI's use of third-party LLMs is private, no information is stored or used to train public models, and all data is stored in a protected and private environment exclusive to Elsevier.

Embase AI is the latest in a series of solutions from Elsevier that have been built in partnership with the research community to help users more easily discover, analyze and synthesize research using trusted content powered by responsible AI.

To request a demo or to learn more about Embase AI, visit our site.

About Elsevier 
A global leader in advanced information and decision support, Elsevier helps to advance science and healthcare, to advance human progress. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,700 employees around the world, including 2,300 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 3,000 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray's Anatomy. Together with the Elsevier Foundation, we work in partnership with the communities we serve to advance inclusion in science, research and healthcare. 

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com.

Video - https://mma.prnewswire.com/media/2717689/Elsevier_Limited.mp4
Logo - https://mma.prnewswire.com/media/2717688/Elsevier_Limited_Logo.jpg

Elsevier Limited Logo

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/elsevier-introduces-embase-ai-to-transform-how-users-discover-analyze-and-draw-critical-insights-from-biomedical-research-302489616.html

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen - Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
boerse | 67974002 |